E
Bloomios, Inc.
BLMS
$0.0012
-$0.0001-7.69%
E
Sell
9/5/2023Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D- on 9/5/2023 due to a large decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.02 to 0.01, and debt to equity increased from -1.9 to -1.66.
Bloomios, Inc. (BLMS) was downgraded to E+ from D- on 9/5/2023 due to a large decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.02 to 0.01, and debt to equity increased from -1.9 to -1.66.
D
Sell
4/21/2023Upgraded
Bloomios, Inc. (BLMS) was upgraded to D- from E+ on 4/21/2023 due to a noticeable increase in the solvency index, growth index and valuation index. Debt to equity declined from -1.11 to -2.29, the quick ratio increased from 0.01 to 0.02, and total revenue increased 76.95% from $1.2M to $2.12M.
Bloomios, Inc. (BLMS) was upgraded to D- from E+ on 4/21/2023 due to a noticeable increase in the solvency index, growth index and valuation index. Debt to equity declined from -1.11 to -2.29, the quick ratio increased from 0.01 to 0.02, and total revenue increased 76.95% from $1.2M to $2.12M.
E
Sell
3/14/2023Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
Bloomios, Inc. (BLMS) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
Bloomios, Inc. (BLMS) was upgraded to D- from E+ on 02/23/2023.
Bloomios, Inc. (BLMS) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
Bloomios, Inc. (BLMS) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
D
Sell
11/23/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to D- from D on 11/23/2022 due to a noticeable decline in the growth index and solvency index. Earnings per share declined from -$0.09 to -$0.1592, EBIT declined 44.25% from -$986.5 to -$1.42M, and the quick ratio declined from 0.02 to 0.01.
Bloomios, Inc. (BLMS) was downgraded to D- from D on 11/23/2022 due to a noticeable decline in the growth index and solvency index. Earnings per share declined from -$0.09 to -$0.1592, EBIT declined 44.25% from -$986.5 to -$1.42M, and the quick ratio declined from 0.02 to 0.01.
D
Sell
5/16/2022Upgraded
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 5/16/2022 due to a noticeable increase in the growth index.
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 5/16/2022 due to a noticeable increase in the growth index.
E
Sell
5/13/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 5/13/2022 due to a decline in the valuation index.
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 5/13/2022 due to a decline in the valuation index.
D
Sell
5/4/2022Upgraded
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 05/04/2022.
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 04/21/2022.
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, efficiency index and solvency index. Net income declined 95.44% from -$296.2 to -$578.9, debt to equity increased from -2.55 to -1.57, and total capital declined 37.87% from $1.6M to $994.6.
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, efficiency index and solvency index. Net income declined 95.44% from -$296.2 to -$578.9, debt to equity increased from -2.55 to -1.57, and total capital declined 37.87% from $1.6M to $994.6.
D
Sell
2/24/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to D from D+ on 2/24/2022 due to a large decline in the total return index and volatility index.
Bloomios, Inc. (BLMS) was downgraded to D from D+ on 2/24/2022 due to a large decline in the total return index and volatility index.
D
Sell
12/29/2021Upgraded
Bloomios, Inc. (BLMS) was upgraded to D+ from D on 12/29/2021 due to a noticeable increase in the total return index, solvency index and growth index.
Bloomios, Inc. (BLMS) was upgraded to D+ from D on 12/29/2021 due to a noticeable increase in the total return index, solvency index and growth index.
D
Sell
5/18/2021Upgraded
XLR Medical Corp. (XLRM) was upgraded to D from E+ on 5/18/2021 due to a large increase in the total return index, efficiency index and valuation index.
XLR Medical Corp. (XLRM) was upgraded to D from E+ on 5/18/2021 due to a large increase in the total return index, efficiency index and valuation index.
E
Sell
3/6/2020Upgraded
XLR Medical Corp. (XLRM) was upgraded to E+ from E- on 3/6/2020 due to an increase in the total return index and growth index. Earnings per share increased from -$0.0001 to $0, EBIT increased 40% from -$1 to -$600, and operating cash flow increased 20% from -$1 to -$800.
XLR Medical Corp. (XLRM) was upgraded to E+ from E- on 3/6/2020 due to an increase in the total return index and growth index. Earnings per share increased from -$0.0001 to $0, EBIT increased 40% from -$1 to -$600, and operating cash flow increased 20% from -$1 to -$800.
E
Sell
10/21/2019Upgraded
XLR Medical Corp. (XLRM) was upgraded to E- from on 10/21/2019 due to a significant increase in the solvency index, efficiency index and total return index. Net income increased 83.05% from -$5.9 to -$1, and total capital increased 33.33% from -$300 to -$200.
XLR Medical Corp. (XLRM) was upgraded to E- from on 10/21/2019 due to a significant increase in the solvency index, efficiency index and total return index. Net income increased 83.05% from -$5.9 to -$1, and total capital increased 33.33% from -$300 to -$200.
OTC PK
04/19/2024 10:36AM Eastern
Quotes delayed
